47 results
424B5
PCSA
Processa Pharmaceuticals Inc
28 May 24
Prospectus supplement for primary offering
4:49pm
in the medical community, if approved;
the implementation of our business model, strategic plans for our business, product candidates and technology … by physicians, patients, third-party payors and others in the medical community, if approved;
the implementation of our business model, strategic plans
424B4
PCSA
Processa Pharmaceuticals Inc
29 Jan 24
Prospectus supplement with pricing info
4:15pm
, and subject to applicable community property laws, the persons named in the table have sole voting and investment power with respect to all shares
424B5
73kvp
24 Mar 22
Prospectus supplement for primary offering
4:15pm
PRE 14A
p10damlk
1 Sep 21
Preliminary proxy
4:46pm
424B5
ggu2h7
20 Aug 21
Prospectus supplement for primary offering
4:46pm
8-K
EX-10.1
cyv2q0s0 tzz7nd7g
17 Jun 21
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117
11:35am